Due to the COVID-19 pandemic, the global Self-Injections market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Self-Injections market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Self-Injections landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Syringe Without Needle accounting for % of the Self-Injections global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Self-Injections include Elcam Medicalcompany Overview, Bespak, Sanofi, Sandoz International Gmbh, Unilife Corporation, West Pharmaceutical Services, Pfizer, Impax Laboratories and Penjet Corporation, etc. In terms of revenue, the global 3 largest players have a % market share of Self-Injections in 2021.
This report focuses on Self-Injections volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Self-Injections market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Self-Injections Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Syringe Without Needle
Automatic Syringe
Pen Type Syringe
Wearable Syringe
Segment by Application
Hospital
Clinic
Pharmaceutical Companies
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Elcam Medicalcompany Overview
Bespak
Sanofi
Sandoz International Gmbh
Unilife Corporation
West Pharmaceutical Services
Pfizer
Impax Laboratories
Penjet Corporation
Crossject Needle-Free Injection Systems
Wilhelm Haselmeier Gmbh & Co. Kg
Antares Pharma
Becton
Gerresheimer Ag
Mylan N.V
Novo Nordisk
Owen Mumford
Pharmajet
Shl Group
Ypsomed
Dickinson And Company